Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drug prices
7
×
indiana blog main
indiana top stories
life sciences
medicare
7
×
national
national blog main
national top stories
new york blog main
7
×
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
novartis
bristol-myers squibb
deals
eli lilly
generic drugs
pfizer
startups
abbvie
alzheimer's disease
biogen
cancer
What
drug
bio
roundup
pharmaceutical
price
prices
companies
drugs
lower
notes
plan
prescription
today
acquisitions
afternoon
airport
albert
alzheimer’s
annual
anticipated
apocalypse
appetite
approval
awaited
away
beds
biggest
biogen’s
biopharmaceutical
black
blueprint
bourla
bread
bringing
butter
buyout
cancer
cash
celgene
ceo
Language
unknown
Current search:
medicare
×
" new york blog main "
×
" drug prices "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details